购物车
- 全部删除
- 您的购物车当前为空
UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay.
UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 17,600 | 8-10周 | |
50 mg | ¥ 22,980 | 8-10周 | |
100 mg | ¥ 32,500 | 8-10周 |
产品描述 | UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay. |
靶点活性 | PAR4:(kd)1.4 nM, PAR4:4 nM |
分子量 | 513.56 |
分子式 | C28H23N3O5S |
CAS No. | 1477497-01-0 |
密度 | 1.36 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容